FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Marcus, Leigh, Fashoyin-Aje, Lola A, Donoghue, Martha, Yuan, Mengdie, Rodriguez, Lisa, Gallagher, Pamela S, Philip, Reena, Ghosh, Soma, Theoret, Marc R, Beaver, Julia A, Pazdur, Richard, Lemery, Steven J
Published in Clinical cancer research (01.09.2021)
Published in Clinical cancer research (01.09.2021)
Get full text
Journal Article
Spontaneous Object Exploration in a Recessive Gene Knockout Model of Parkinson's Disease: Development and Progression of Object Recognition Memory Deficits in Male Pink1-/- Rats
Pinizzotto, Claudia C, Dreyer, Katherine M, Aje, Oluwagbohunmi A, Caffrey, Ryan M, Madhira, Keertana, Kritzer, Mary F
Published in Frontiers in behavioral neuroscience (06.12.2022)
Published in Frontiers in behavioral neuroscience (06.12.2022)
Get full text
Journal Article
Effect of educational intervention on medication reconciliation practice of hospital pharmacists in a developing country – A non-randomised controlled trial
Aje, Akinniyi A, Showande, Segun J, Adisa, Rasaq, Fakeye, Titilayo O, Olutayo, Oluwakemi A, Adebusoye, Lawrence A, Olowookere, Olufemi O
Published in BMC medical education (15.11.2023)
Published in BMC medical education (15.11.2023)
Get full text
Journal Article
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
Maignan, Kathleen, Fashoyin-Aje, Lola A, Torres, Aracelis Z, Fernandes, Laura L, Gwise, Thomas, Baxi, Shrujal B, Roose, James P, Rivera, Donna R, Shen, Yuan Li, Kluetz, Paul G, Gormley, Nicole J
Published in Blood cancer journal (New York) (19.04.2022)
Published in Blood cancer journal (New York) (19.04.2022)
Get full text
Journal Article
The On- and Off-Ramps of Oncology Accelerated Approval
Fashoyin-Aje, Lola A., Mehta, Gautam U., Beaver, Julia A., Pazdur, Richard
Published in The New England journal of medicine (20.10.2022)
Published in The New England journal of medicine (20.10.2022)
Get full text
Journal Article
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation
Casak, Sandra J, Pradhan, Shan, Fashoyin-Aje, Lola A, Ren, Yi, Shen, Yuan-Li, Xu, Yuan, Chow, Edwin Chiu Yuen, Xiong, Ye, Zirklelbach, Jeanne Fourie, Liu, Jiang, Charlab, Rosane, Pierce, William F, Fesenko, Nataliya, Beaver, Julia A, Pazdur, Richard, Kluetz, Paul G, Lemery, Steven J
Published in Clinical cancer research (01.07.2022)
Published in Clinical cancer research (01.07.2022)
Get full text
Journal Article
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma
Patel, Timil H, Brewer, Jamie R, Fan, Jiaxin, Cheng, Joyce, Shen, Yuan-Li, Xiang, Yue, Zhao, Hong, Lemery, Steven J, Pazdur, Richard, Kluetz, Paul G, Fashoyin-Aje, Lola A
Published in Clinical cancer research (17.01.2024)
Published in Clinical cancer research (17.01.2024)
Get full text
Journal Article
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
Patel, Timil H, Marcus, Leigh, Horiba, M Naomi, Donoghue, Martha, Chatterjee, Somak, Mishra-Kalyani, Pallavi S, Schuck, Robert N, Li, Yangbing, Zhang, Xinyuan, Fourie Zirkelbach, Jeanne, Charlab, Rosane, Liu, Jiang, Yang, Yuching, Lemery, Steven J, Pazdur, Richard, Theoret, Marc R, Fashoyin-Aje, Lola A
Published in Clinical cancer research (01.03.2023)
Published in Clinical cancer research (01.03.2023)
Get full text
Journal Article
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Casak, Sandra J, Horiba, M Naomi, Yuan, Mengdie, Cheng, Joyce, Lemery, Steven J, Shen, Yuan Li, Fu, Wentao, Moore, Jason N, Li, Yangbing, Bi, Youwei, Auth, Doris, Fesenko, Nataliya, Kluetz, Paul G, Pazdur, Richard, Fashoyin-Aje, Lola A
Published in Clinical cancer research (01.11.2023)
Published in Clinical cancer research (01.11.2023)
Get full text
Journal Article
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer
Casak, Sandra J., Kumar, Vaibhav, Song, Chi, Yuan, Mengdie, Amatya, Anup K., Cheng, Joyce, Mishra-Kalyani, Pallavi S., Tang, Shenghui, Lemery, Steven J., Auth, Doris, Davis, Gina, Kluetz, Paul G., Pazdur, Richard, Fashoyin-Aje, Lola A.
Published in Clinical cancer research (15.08.2024)
Published in Clinical cancer research (15.08.2024)
Get full text
Journal Article
Driving Diversity and Inclusion in Cancer Drug Development - Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges
Fashoyin-Aje, Lola A, Tendler, Craig, Lavery, Bea, Ghiorghiu, Serban, Gerald, Brittany, Kalidas, Chitkala, Richie, Nicole, Winson, Kathleen, Warren, Nicholas J H, Tellman, Tristen V, Retzlaff, Jon, Foti, Margaret, Pazdur, Richard
Published in Clinical cancer research (15.09.2023)
Published in Clinical cancer research (15.09.2023)
Get full text
Journal Article
Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials
Lichtenstein, Morgan R L, Levit, Laura A, Schenkel, Caroline, Kirkwood, Kelsey, Fashoyin-Aje, Lola A, Bruinooge, Suanna S, Kelley, Michael J, Mailman, Josh A, Magnuson, Allison, Mirda, Daniel P, Natesan, Divya, Hershman, Dawn L
Published in The oncologist (Dayton, Ohio) (04.04.2024)
Published in The oncologist (Dayton, Ohio) (04.04.2024)
Get full text
Journal Article
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor
Kumar, Vaibhav, Doros, Leslie, Thompson, Margaret, Mushti, Sirisha L, Charlab, Rosane, Spehalski, Elizabeth I, Zhao, Hong, Thompson, Matthew D, Tang, Shenghui, Pazdur, Richard, Lemery, Steven J, Theoret, Marc R, Fashoyin-Aje, Lola A
Published in Clinical cancer research (01.06.2023)
Published in Clinical cancer research (01.06.2023)
Get full text
Journal Article
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Gandhy, Shruti U, Casak, Sandra J, Mushti, Sirisha L, Cheng, Joyce, Subramaniam, Sriram, Zhao, Hong, Zhao, Miao, Bi, Youwei, Liu, Guansheng, Fan, Jianghong, Adeniyi, Oluseyi, Charlab, Rosane, Kufrin, Dubravka, Thompson, Matthew D, Jarrell, Kristin, Auth, Doris, Lemery, Steven J, Pazdur, Richard, Kluetz, Paul G, Fashoyin-Aje, Lola A
Published in Clinical cancer research (13.10.2023)
Published in Clinical cancer research (13.10.2023)
Get full text
Journal Article
FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease
Horiba, M Naomi, Casak, Sandra J, Mishra-Kalyani, Pallavi S, Roy, Pourab, Beaver, Julia A, Pazdur, Richard, Kluetz, Paul G, Lemery, Steven J, Fashoyin-Aje, Lola A
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples
Amatya, Anup K, Fiero, Mallorie H, Bloomquist, Erik W, Sinha, Arup K, Lemery, Steven J, Singh, Harpreet, Ibrahim, Amna, Donoghue, Martha, Fashoyin-Aje, Lola A, de Claro, R Angelo, Gormley, Nicole J, Amiri-Kordestani, Laleh, Sridhara, Rajeshwari, Theoret, Marc R, Kluetz, Paul G, Pazdur, Richard, Beaver, Julia A, Tang, Shenghui
Published in Clinical cancer research (01.11.2021)
Published in Clinical cancer research (01.11.2021)
Get full text
Journal Article
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
Fusco, Michael J, Casak, Sandra J, Mushti, Sirisha L, Cheng, Joyce, Christmas, Brian J, Thompson, Matthew D, Fu, Wentao, Wang, Hezhen, Yoon, Miyoung, Yang, Yuching, Moore, Jason N, Bi, Youwei, Nan, Yang, Long, Craig E, Auth, Doris, Rahman, Nam Atiqur, Tang, Shenghui, Pazdur, Richard, Fashoyin-Aje, Lola A, Kluetz, Paul G, Lemery, Steven J
Published in Clinical cancer research (01.08.2024)
Published in Clinical cancer research (01.08.2024)
Get full text
Journal Article
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written Requests
Fashoyin-Aje, Lola A, Akalu, Alemayehu Y, Boehmer, Jessica, Pazdur, Richard, Donoghue, Martha, Reaman, Gregory H
Published in JAMA oncology (01.03.2024)
Published in JAMA oncology (01.03.2024)
Get more information
Journal Article